Recommendations of the Slovak IBD Working Group on SGS for the Treatment of Biosimilar Anti-TNF Biologics in Adult and Pediatric Patients
																	
									Authors:
											Kadlečková B.						1,2; 											Šturdík I.						3; 											Lietava P.						4; 											Gombošová L.						5; 											Čierna I.						6; 											Hlavaty T.						7; 											Huorka M.						3										
				
									Authors‘ workplace:
											Gastroenterologické oddelenie, UN – Nemocnica sv. Michala a.  s., Bratislava
						1; 											Gastroenterologické centrum ASSIDUO, Bratislava
						2; 											Gastroenterologické a hepatologické oddelenie, V. interná klinika LF UK a UN Bratislava
						3; 											Interná klinika gastroenterologická JLF UK a UN Martin
						4; 											I. interná klinika LF Univerzity P. J. Šafárika a UN L. Pasteura, Košice
						5; 											Detská klinika LF UK a NÚDCH, Bratislava
						6; 											V. interná klinika LF UK a UN Bratislava
						7										
				
									Published in:
					Gastroent Hepatol 2020; 74(2): 130-134
					
				
									Category:
					IBD: Guidelines
					
				
									doi:
					
						https://doi.org/10.14735/amgh2020130
					
							
Labels
Paediatric gastroenterology Gastroenterology and hepatology SurgeryArticle was published in
Gastroenterology and Hepatology
					2020 Issue 2
- Metamizole vs. Tramadol in Postoperative Analgesia
 - Current Insights into the Antispasmodic and Analgesic Effects of Metamizole on the Gastrointestinal Tract
 - Spasmolytic Effect of Metamizole
 - Metamizole in the Treatment of Acute Postoperative Pain
 - Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
 
Most read in this issue
- Covid-19 and the liver
 - Endoscopic drainage of infected pancreatic necrosis with complicated course – case report
 - Guideline of the Czech Hepatology Society of the ČLS JEP for diagnosis and treatment of non-alcoholic fatty liver disease
 - Doporučení pro léčbu idiopatických střevních zánětů v době pandemie covid-19